Literature DB >> 7876643

History and epidemiology of hepatitis A virus.

J L Melnick1.   

Abstract

Hepatitis A was clearly recognized as an entity separate from other types of hepatitis during World War II, but only later did studies provide convincing evidence of the prevalence and transmission of hepatitis A virus (HAV). Disease incidence varies over time and geography, with wide differences from country to country and even within cities. Noted recently is a shift in prevalence in cases from childhood to adulthood. Incidence figures are unreliable. Epidemiology of the disease is best defined by measurement of anti-HAV antibodies. HAV is a very stable virus, frequently found in urban sewage. Infections occur early in life when sanitation is poor and living conditions crowded, but improvements in sanitation and hygiene have delayed infection, resulting in increasing numbers of adults susceptible to HAV. Transmission of HAV by blood is rare. High-risk persons include injection drug users, institutionalized persons and their caretakers, and those who travel from low-prevalence to high-prevalence countries.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7876643     DOI: 10.1093/infdis/171.supplement_1.s2

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  23 in total

Review 1.  Considerations of HAV vaccine in India.

Authors:  P Mathur; N K Arora
Journal:  Indian J Pediatr       Date:  1999 Jan-Feb       Impact factor: 1.967

2.  Hepatitis A seroprevalence in Slovene travellers.

Authors:  M Socan; A Kraigher; N Fiser-Marinic
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

3.  Population-based survey of hepatitis A virus infection in the Republic of San Marino.

Authors:  T Stroffolini; S Pretolani; F Miglio; M Rapicetta; U Villano; F Bonvicini; L Baldini; F Sampogna; G Giulianelli; M L Stefanelli; A Carloni; A Sorcinelli; G Ghironzi; G Gasbarrini
Journal:  Eur J Epidemiol       Date:  1997-09       Impact factor: 8.082

4.  Age-specific seroepidemiology of hepatitis A, B, and E infections among children in Istanbul, Turkey.

Authors:  M Sidal; E Unüvar; F Oğuz; C Cihan; D Onel; S Badur
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

5.  Presence of oligoclonal T cells in cerebrospinal fluid of a child with multiphasic disseminated encephalomyelitis following hepatitis A virus infection.

Authors:  E L Oleszak; W L Lin; A Legido; J Melvin; H Hardison; B E Hoffman; C D Katsetos; C D Platsoucas
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

6.  Prevalence of antibodies against enterically transmitted viral hepatitis (HAV and HEV) among adolescents in an inland territory of central Italy.

Authors:  G Ripabelli; M L Sammarco; T Campo; C Montanaro; E D'Ascenzo; G M Grasso
Journal:  Eur J Epidemiol       Date:  1997-01       Impact factor: 8.082

7.  Seroprevalence of hepatitis A immunity in male genitourinary medicine clinic attenders: a case control study of heterosexual and homosexual men.

Authors:  J D C Ross; M Ghanem; A Tariq; G Gilleran; A J Winter
Journal:  Sex Transm Infect       Date:  2002-06       Impact factor: 3.519

8.  Foodborne spread of hepatitis A: Recent studies on virus survival, transfer and inactivation.

Authors:  S A Sattar; T Jason; S Bidawid; J Farber
Journal:  Can J Infect Dis       Date:  2000-05

9.  Age-specific seroprevalence of hepatitis A infection among children visited in pediatric hospitals of Tehran, Iran.

Authors:  Ali Jafari Mehr; Mohammad Javad Ehsani Ardakani; Mehdi Hedayati; Saeed Shahraz; Elnaz Jafari Mehr; Mohammad Reza Zali
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

10.  Sporadic acute hepatitis E occurred constantly during the last decade in northeast Japan.

Authors:  Jun Inoue; Yoshiyuki Ueno; Futoshi Nagasaki; Takehiro Akahane; Koji Fukushima; Takayuki Kogure; Yasuteru Kondo; Eiji Kakazu; Keiichi Tamai; Osamu Kido; Yu Nakagome; Masashi Ninomiya; Noriyuki Obara; Yuta Wakui; Masaharu Takahashi; Hiroaki Okamoto; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2009-03-07       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.